Back to top

Why IDEXX Laboratories (IDXX) Isn't Done Growing Earnings Yet
August 24, 2017

Read MoreHide Full Article

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, these can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.

One such company that might be well-positioned for future earnings growth is IDEXX Laboratories, Inc. (IDXX - Free Report) . This firm, which is in the Medical-Instruments industry, saw EPS growth of 18.5% last year, and is looking great for this year too.

In fact, the current growth estimate for this year calls for earnings-per-share growth of 27%. Furthermore, the long-term growth rate is currently an impressive 19.8%, suggesting pretty good prospects for the long haul.

IDEXX Laboratories, Inc. Price and Consensus

And if this wasn’t enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 3.9%. Thanks to this rise in earnings estimates, IDXX has a Zacks Rank #2 (Buy) which further underscores the potential for outperformance in this company. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So if you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider IDXX. Not only does it have double digit earnings growth prospect, but its impressive Zacks Rank suggests that analysts believe better days are ahead for IDXX as well.

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>
 




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


IDEXX Laboratories, Inc. (IDXX) - free report >>


More from Zacks Tale of the Tape

You May Like